Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP), Gilead Sciences (NASDAQ:GILD)

Progenics Pharmaceuticals, Inc. PGNX was a big mover last session, as the company saw its shares rise over 9% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $3.43 to $4.06 in the past one-month time frame.

The company has seen 1 negative revision in the past 1 month, while its Zacks Consensus Estimate of a loss widened over the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Progenics Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other players in the healthcare industry include Illumina Inc. ILMN, Gilead Sciences Inc. GILD and ANI Pharmaceuticals, Inc. ANIP all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

PROGENICS PHARM PGNX: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

ILLUMINA INC ILMN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs